In low- and middle-income nations where the disease kills more than 3,00,000 women annually, Rice University bioengineers have demonstrated a low-cost, point-of-care DNA test for HPV infections that may make cervical cancer screening more accessible.
Over the past ten years, an increase in head and neck malignancies has been related to human papillomavirus (HPV). For instance, studies show that 70 per cent of oropharyngeal cancer occurrences in the US are caused by HPV.
Human papillomavirus (HPV) has been linked to a rising number of head and neck cancers over the past ten years. For instance, research indicates that HPV is responsible for 70 per cent of oropharyngeal cancer cases in the US.
Three batches of approximately 80,000 doses of HPV vaccine have been released by Central drugs laboratory (CDL) in, Kasauli, Himachal Pradesh, sources said to ANI
World Health Organisation has called for intensified action across the South-East Asia Region to strengthen health systems to prevent and detect cancers early, to provide prompt treatment referral, to enhance access to palliative care, and to close the gap in access to quality cancer service
In the upcoming Union Budget 2023-24, the focus is expected to be on increasing the number of nursing colleges, and medical colleges, introducing of HPV vaccine in the National Immunisation Program and enhancement of Pradhanmantri Jan Arogya Yojana (PMJAY) coverage, the sources informed.
Serum Institute of India Director Prakash Kumar Singh on Thursday presented Made in India HPV Vaccine Cervavac to Union Minister Jitendra Singh at the Union Minister's residence.
Adar Poonawalla said that the availability of the Human Papillomavirus (HPV) vaccine will be little in number this year, however, it would be boosted next year.
Certain vaccine-related issues have been shown by research that medical professionals should address. Young cancer survivors are more likely to eventually develop cervical, oropharyngeal, and a number of other HPV-related malignancies, despite the fact that HPV vaccination rates in this popu
The Human Papillomavirus (HPV) CERVAVAC vaccine, for the prevention of cervical cancer, is expected to arrive in India by April at the one-tenth of the cost of internationally branded vaccines in the country, said Dr NK Arora, chairman of the Covid working group, National Technical Adviso